Cancer diagnostics company, Pacific Edge, has corrected a press release regarding its financial results for the six months ended September 2024.
The company clarified that the financial statements are unaudited, contrary to the earlier claim in the headline.
However, it noted that the statements have been reviewed by its auditors, PwC.
See more
The cancer diagnostics company is awaiting outcomes of several events.
Blis has reported an increase in revenue and earnings despite a patent dispute.
Software firm won't pay dividend as it plans for more growth in consolidating markets.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details
